Literature DB >> 9372384

Esophageal cancer in patients with head and neck cancers.

H Miyazato1, O Tamai, S Tomita, M Shiraishi, T Kusano, Y Muto, S Koja.   

Abstract

Nine male patients with separate primary cancers of the esophagus and head and neck (pharynx, larynx) presented with a mean age of 56 years (41-69). They included 7 pharyngeal cancer patients and 2 laryngeal ones. Esophageal cancer was discovered synchronously in 6 patients and metachronously in 3 (1, 4, and 11 years later, respectively). The head and neck cancer was stage-I in one patient, stage-II in 4 and stage-IV in 4. The esophageal cancer was cervical in 2, thoracic in 6 and abdominal in 1. It was early cancer (stage-0) in 6 patients and advanced (stage-IV) in 3. The esophageal cancer was more advanced in the metachronous group, while it was early in the synchronous group. Since the head and neck cancer was advanced, all patients underwent a total laryngectomy for their head and neck cancers. As for esophageal surgery, a transhiatal esophagectomy was, in principle, performed for early cancers while a total thoracic esophagectomy was done for advanced cancers. For the reconstruction of the esophagus, a gastric tube was used. Four patients are still alive with a mean survival time of 25 months, whereas five died of cancer recurrence of either type a mean of 19 months after surgery. As compared with the survival rates of the patients with esophageal cancer alone, the 5-year survival rate was 18.2% for patients with double cancers in this series and 27.9% for those with esophageal cancer alone.

Entities:  

Mesh:

Year:  1997        PMID: 9372384

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  2 in total

1.  A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report.

Authors:  Yoritaka Matsuno; Mitsugu Kochi; Masashi Fujii; Noriaki Kanamori; Teruo Kaiga; Yoshiaki Mihara; Tomoya Funada; Teruyuki Miyazaki; Tadatoshi Takayama
Journal:  World J Surg Oncol       Date:  2012-07-03       Impact factor: 2.754

2.  Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Authors:  Yen-Hao Chen; Hung-I Lu; Chih-Yen Chien; Chien-Ming Lo; Yu-Ming Wang; Shang-Yu Chou; Yan-Ye Su; Li-Hsueh Shih; Shau-Hsuan Li
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.